Side-by-side comparison of AI visibility scores, market position, and capabilities
Denver CO AI platform (NYSE: PLTR) $2.87B FY2024 revenue (+29%); US Commercial +54%, AIP boot camps, S&P 500 addition Sept 2024, competing with Microsoft Azure AI and C3.ai.
Palantir Technologies Inc. is a Denver, Colorado-based artificial intelligence and data analytics platform company — publicly traded on the New York Stock Exchange (NYSE: PLTR) as an S&P 500 Technology component (added September 2024) — building software platforms for government intelligence and defense analytics (Gotham), commercial enterprise AI operations (Foundry), and the Palantir Artificial Intelligence Platform (AIP) for enterprise AI deployment through approximately 3,800 employees. In fiscal year 2024, Palantir reported revenues of $2.87 billion (+29% year-over-year), with US Commercial revenue reaching $702 million (+54%), US Government revenue $912 million (+40%), and International revenue $1.26 billion (+13%) — demonstrating the acceleration of AI-driven commercial adoption beyond Palantir's defense intelligence origins. CEO Alex Karp's strategy of positioning Palantir as the enterprise AI operating system — the platform on which organizations deploy, govern, and scale AI agents and large language models in production — drove AIP adoption through Palantir's "boot camp" methodology: a 5-day intensive workshop where potential customers deploy AIP on their own data to demonstrate specific use cases before any contract commitment, reducing enterprise AI proof-of-concept cycle time from months to days. The S&P 500 inclusion in September 2024 triggered index fund purchases and elevated Palantir's institutional ownership profile, with the stock price rising from approximately $17 to over $70 during 2024 as AI platform enthusiasm drove valuation expansion to 50-80x forward revenue multiples.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.